Background {#section1-2333392819852879}
==========

The manifestation of type 2 diabetes (T2D) may last several years without noticeable symptoms.^[@bibr1-2333392819852879]^ It has been repeatedly shown that patients with diabetes already have an increased prevalence of complications at the time of diagnosis.^[@bibr2-2333392819852879],[@bibr3-2333392819852879]^ Therefore, more attention needs to be paid to the detection and initiation of care for T2D in order to avoid serious complications.

Electronic health records (EHRs) have great potential for the surveillance of T2D prevalence, as well as for monitoring and improving the processes and quality of diabetes care.^[@bibr4-2333392819852879],[@bibr5-2333392819852879]^ Further, by combining the health records and geographic information, it is possible to map areas where the detection and treatment of diabetes needs to be improved.^[@bibr6-2333392819852879][@bibr7-2333392819852879]-[@bibr8-2333392819852879]^ The use of EHRs to identify evidence-treatment gaps in the treatment of patients with noncommunicable diseases has been scarce, especially in primary health care.

In the region of the Joint Municipal Authority for North Karelia Social and Health Services (Siun sote) in Finland, the regional EHRs covering both primary and specialized health care enable flexible data retrieval and area-level analyses. In addition, the database of the Finnish Social Insurance Institution contains data on medication reimbursement rights. Using these data sources, the aim of this study was to assess the activities performed in order to improve the detection of T2D in the region between 2012 and 2017 and to evaluate the coverage of T2D diagnoses found in the EHRs.

Methods {#section2-2333392819852879}
=======

The number of patients with T2D in the Siun sote region was identified from the health records. The identification of patients was done using the *ICD-10* code E11 that is registered during any visit to either primary or specialized care. The data were collected for the period 2011 to 2017. The age-standardized prevalence of T2D was calculated for the years 2012, 2015, and 2017 on the municipality level in 14 municipalities of the region ([Figure 1](#fig1-2333392819852879){ref-type="fig"}). Solely patients whose place of domicile was on record and who were alive at the end of 2012, 2015, and 2017 were considered when the prevalence was calculated. The prevalence rates were age-standardized to the population of the study region for each observed year. The rates were mapped using geographic information system software ArcGIS 10.4.1.

![The age-standardized prevalence of T2D in the municipalities of the Joint Municipal Authority for North Karelia Social and Health Services (Siun sote) in 2012, 2015, and 2017.](10.1177_2333392819852879-fig1){#fig1-2333392819852879}

The statistical database of the Social Insurance Institution of Finland, Kelasto, contains data on medication reimbursement rights. We evaluated the coverage of T2D diagnoses found in the EHRs with the counts received from the medication reimbursement rights database. Eligibility for reimbursement is based upon diagnosis, not the specific medication classes used. However, the registration code for the right to diabetes medication reimbursement in the database includes both type 1 diabetes and T2D and these cannot be separated. For this reason, patients with the diagnosis of type 1 diabetes were also included in the comparison.

Quality improvement activities, such as quarterly workshops for professionals and visits and guidance by diabetologist in charge to improve practices, have been regularly performed inside the regional network of professionals treating diabetes patients in the Siun sote service area since the 1980s. The network has also participated in the development of regional EHR systems and reporting tools since the regional EHR was introduced in 2010. Professionals are able to produce the basic reports themselves from the system. The data from EHRs are also used to identify area-level differences in the detection of T2D and evidence-treatment gaps. The quality-of-care reports have been regularly presented and discussed in the network meetings.

Results {#section3-2333392819852879}
=======

In 2012, the age-adjusted prevalence of T2D according to the EHRs in the Siun sote region varied considerably between municipalities ([Figure 1](#fig1-2333392819852879){ref-type="fig"}). The highest prevalence of 8.6% in one municipality was significantly higher compared with other municipalities, indicating better detection of the disease. In 2017, the differences between the municipalities had notably diminished, and in most municipalities, the prevalence exceeded 8%. Only in 2 municipalities was the prevalence of diabetes still lower than in other municipalities.

In 2012, 2015, and 2017, the number of patients with diabetes was higher in the data from EHRs than in the medication reimbursement rights data from the Finnish Social Insurance Institution ([Table 1](#table1-2333392819852879){ref-type="table"}), with the exception of 2 municipalities in 2012. The regional differences in the prevalence of T2D and their downward trend from 2012 to 2017 were observed in both data sources.

###### 

The Number of Patients with Type 1 Diabetes and T2D According to the EHRs of the Joint Municipal Authority for North Karelia Social and Health Services and the Finnish Register of Medication Reimbursement Rights in 2012, 2015, and 2017, and the Ratio Between Them, Expressed as a Proportion.

![](10.1177_2333392819852879-table1)

  Municipality   2012   2015    2017                                                                 
  -------------- ------ ------- ------- ------- ------ ------- ------- ------ ------ ------- ------- ------
  Heinävesi      31     323     320     90.4    26     427     370     81.7   29     437     378     81.1
  Ilomantsi      32     535     493     86.9    37     643     549     80.7   31     645     574     84.9
  Joensuu        668    3785    4001    89.8    704    4560    4591    87.2   676    4868    4904    88.5
  Juuka          36     479     478     92.8    36     521     495     88.9   39     561     511     85.2
  Kitee          83     732     803     98.5    85     991     977     90.8   92     1075    1062    91.0
  Kontiolahti    109    552     594     89.9    123    631     682     90.5   119    726     756     89.5
  Lieksa         100    1034    896     79.0    97     1187    1090    84.9   93     1278    1175    85.7
  Liperi         90     794     691     78.2    94     889     793     80.7   90     926     820     80.7
  Nurmes         56     640     723     103.9   55     771     780     94.4   59     803     811     94.1
  Outokumpu      60     703     602     78.9    61     721     643     82.2   58     747     683     84.8
  Polvijärvi     47     325     362     97.3    45     427     390     82.6   43     458     408     81.4
  Rääkkylä       25     217     189     78.1    20     291     242     77.8   20     307     261     79.8
  Tohmajärvi     23     402     405     95.3    29     442     451     95.8   32     467     454     91.0
  Valtimo        19     178     206     104.6   21     251     234     86.0   21     247     238     88.8
  Total          1379   10699   10443   86.5    1433   12752   11917   84.0   1402   13545   12657   84.7

^a^The number of people with diabetes in the Finnish Register of Medication Reimbursement Rights divided by the number of people with diabetes in the EHRs of the Joint Municipal Authority for North Karelia Social and Health Services (the ratio is expressed as a proportion).

The ratio between the number of patients in the national medication reimbursement rights register and in the regional EHRs has been very stable during the observed time period ([Table 1](#table1-2333392819852879){ref-type="table"}). However, in some municipalities, the ratio has decreased from the year 2012. This could be partly explained by the improved recording of diagnoses for health care visits in the regional patient register.

Conclusions {#section4-2333392819852879}
===========

Previous studies have shown that it is possible to observe the area-level differences or differences by service provider in processes and quality of care by comparing data from EHRs.^[@bibr9-2333392819852879][@bibr10-2333392819852879][@bibr11-2333392819852879]-[@bibr12-2333392819852879]^ Data are especially useful when explanatory factors other than health care processes (such as demographic determinants) can be taken into account. Further, the possibility to indicate the changes in processes using health record data from different years is valuable.

In this study, quite significant differences were found in the age-adjusted prevalence of T2D between the municipalities in 2012, most likely due to differences in the detection of T2D. These differences considerably diminished from 2012 to 2017, indicating the improvement in the processes resulting from the quality improvement activities which were performed inside the regional network of professionals treating patients with diabetes.

Increasing age is a significant risk factor for T2D. Also, lower socioeconomic status is associated with the higher risk of T2D^[@bibr13-2333392819852879][@bibr14-2333392819852879]-[@bibr15-2333392819852879]^ and with worse treatment outcomes.^[@bibr16-2333392819852879]^ Apart from age, the population characteristics in this rather remote area are reasonably similar. However, socioeconomic differences could partly explain the lower prevalence of T2D in 2 central municipalities with a younger and more highly educated population.^[@bibr16-2333392819852879]^

The disparities in recording practices could be one reason for the observed differences in the prevalence of T2D between municipalities in the year 2012. However, the data comparisons showed that between the years, the number of patients was very similar in most of the municipalities, both in the EHRs and in the medication reimbursement rights register, and therefore, the differences are not concluded to only be caused by disparities in recording practices. The smaller number of diabetes cases in the medication reimbursement rights register is partly explained by the delay in applying for and granting a special reimbursement right and by the proportion of patients with dietary treatment only. This study shows that the EHRs do not underestimate the number of people with diabetes.

This study confirms that the EHRs are a valuable data source for knowledge-based management and quality improvement. There were real differences in the identification of T2D between the municipalities of North Karelia in 2012, but after visualizing these differences and providing information for the service system and professionals, the detection of T2D improved and the regional differences decreased. The information received from the EHRs needs to be transferred to the field and scaled up to real actions in order to achieve improvements in the processes currently in force. The findings from EHRs in North Karelia have been discussed with the professionals in order to raise awareness of the differences in processes, to find explanations, and to adopt best practices and harmonize them regionally.
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